Skip to main content

UBS Group AG

Position in NEO — Neogenomics Inc

CIK 1610520 ZURICH, V8

Position in NEO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,391,671
+$6,978,488 QoQ
Shares Held
575,166
+202.0% QoQ
Ownership
0.448%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Derivatives in NEO

reported options exposure · as of Jun 30, 2026
CallValue
$32,581,658
CallShares
2,233,150
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,492,966,338 across 42 Diagnostics & Research names. NEO ranks #24 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NEO

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,581,658 2,233,150
2026-06-30 $8,391,671 575,166
2026-03-31 $1,413,183 190,456
2025-12-31 $4,087,469 347,574
2025-09-30 $6,208,809 804,250
2025-06-30 $2,747,132 375,805
2025-03-31 $4,729,064 498,321
2024-12-31 $7,027,070 426,400
2024-09-30 $2,044,850 138,634
2024-06-30 $1,040,553 75,022
2024-03-31 $1,233,280 78,453
2024-03-31 $724,692 46,100
2023-12-31 $1,684,774 104,127
2023-09-30 $411,237 33,434
2023-06-30 $1,904,776 118,530
2023-03-31 $1,526,507 87,680
2022-12-31 $744,669 80,592
2022-09-30 $325,259 37,777
2022-06-30 $240,742 29,539
2022-03-31 $631,423 51,969
2021-12-31 $2,848,166 83,475
2021-09-30 $3,993,403 82,782
2021-06-30 $1,800,882 39,869
2021-03-31 $3,621,252 75,083
2020-12-31 $6,251,900 116,120
2020-09-30 $2,910,989 78,910
2020-06-30 $2,928,507 94,529
2020-03-31 $3,336,695 120,851